Diplomate in Medical Laboratory Immunology Certification Examination: A New Chapter for Medical Laboratory Immunology.


Journal

ImmunoHorizons
ISSN: 2573-7732
Titre abrégé: Immunohorizons
Pays: United States
ID NLM: 101708159

Informations de publication

Date de publication:
01 08 2023
Historique:
received: 24 04 2023
accepted: 03 08 2023
medline: 29 8 2023
pubmed: 28 8 2023
entrez: 28 8 2023
Statut: ppublish

Résumé

It is indeed a privilege to be an immunologist in what is arguably the golden age of immunology. From astounding advances in fundamental knowledge to groundbreaking immunotherapeutic offerings, immunology has carved out an enviable niche for itself in basic science and clinical medicine. The need and the vital importance of appropriate education, training, and certification in clinical immunology was recognized by the World Health Organization as far back as 1972. In the United States, Ph.D. scientists with board certification in medical laboratory immunology have served as directors of high-complexity Clinical Laboratory Improvement Amendments- and College of American Pathologists-certified clinical immunology laboratories since 1977. From 1977 to 2017, board certification for medical laboratory immunology was administered by the American Society for Microbiology through the American Board of Medical Laboratory Immunology examination. The American Board of Medical Laboratory Immunology examination was phased out in 2017, and in the fall of 2019, the American Society for Clinical Pathology (ASCP) Board of Certification (BOC) examination committee took on the responsibility of developing a new doctoral-level certification examination for medical laboratory immunology. This transition to the ASCP BOC represents a well-deserved and much-needed recognition of the rapid advances in and the highly specialized nature of medical laboratory immunology and its ever-increasing relevance to patient care. This new ASCP BOC certification is called the Diplomate in Medical Laboratory Immunology, and, as of April 1, 2023, it is now available to potential examinees. In this report, we describe the examination, eligibility routes, and potential career pathways for successful diplomates.

Identifiants

pubmed: 37639224
pii: 265880
doi: 10.4049/immunohorizons.2300030
pmc: PMC10587505
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

600-610

Informations de copyright

Copyright © 2023 The Authors.

Références

World Health Organ Tech Rep Ser. 1972;496:1-50
pubmed: 4623905
Nature. 2022 Feb;602(7897):503-509
pubmed: 35110735
Front Immunol. 2022 Sep 13;13:937738
pubmed: 36177024
J Allergy Clin Immunol. 2018 Jan;141(1):435-439.e7
pubmed: 28927822
Am J Clin Pathol. 2014 Oct;142(4):437-44
pubmed: 25239409
Haematologica. 2007 Mar;92(3):e43-5
pubmed: 17405757
J Allergy Clin Immunol. 1983 Aug;72(2):121-2
pubmed: 6886251
Ann Intern Med. 1988 Mar;108(3):458-9
pubmed: 3341676
Pediatr Blood Cancer. 2023 May 30;:e30478
pubmed: 37254476
Lancet. 1976 Aug 28;2(7983):459-61
pubmed: 73754
Proc R Soc Med. 1972 Dec;65(12):1093-4
pubmed: 4651396
Lancet. 1976 Aug 28;2(7983):450-1
pubmed: 73748
Eur J Hum Genet. 2022 Sep;30(9):991-992
pubmed: 35075300
Autoimmun Rev. 2014 Apr-May;13(4-5):513-7
pubmed: 24424195
Immunol Res. 2020 Feb;68(1):13-27
pubmed: 32215810
Lancet. 1976 Dec 4;2(7997):1247
pubmed: 63067
J Allergy Clin Immunol. 2015 Apr;135(4):1093-1096.e8
pubmed: 25843602
Biomedicines. 2023 Mar 21;11(3):
pubmed: 36979938
Proc Biol Sci. 2015 Dec 22;282(1821):20143085
pubmed: 26702035
Immun Inflamm Dis. 2018 Sep;6(3):377-381
pubmed: 29701015
Am J Clin Pathol. 2019 Feb 4;151(3):270-274
pubmed: 30339188
Acad Pathol. 2018 Jun 04;5:2374289518775948
pubmed: 29888322
Lancet. 1976 Sep 25;2(7987):685-6
pubmed: 60539
Blood. 2018 Oct 4;132(14):1478-1485
pubmed: 30012636
Bioanalysis. 2018 Jun 1;10(12):957-968
pubmed: 29923754
Bull World Health Organ. 1994;72(4):543-51
pubmed: 7923535
J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S774-8
pubmed: 12592322
J Allergy Clin Immunol. 1972 Nov;50(5):294-304
pubmed: 4403940
Clin Chem Lab Med. 2015 Jan;53(1):5-14
pubmed: 25029085
J Clin Microbiol. 2021 Nov 18;59(12):e0021321
pubmed: 34550809
J Allergy Clin Immunol. 1990 Dec;86(6 Pt 1):961-2
pubmed: 2262651
MAbs. 2022 Jan-Dec;14(1):2014296
pubmed: 35030985
Immunohorizons. 2020 Apr 10;4(4):153-164
pubmed: 32276922
Clin Lab Med. 2007 Sep;27(3):627-52, viii
pubmed: 17658410
MLO Med Lab Obs. 2012 Jan;44(1):30, 32
pubmed: 22352183
Lancet. 1976 Apr 10;1(7963):796-7
pubmed: 56603
Front Immunol. 2019 Jul 16;10:1632
pubmed: 31379835
J Clin Immunol. 2011 Aug;31(4):533-6
pubmed: 21584708
J Clin Immunol. 2022 Oct;42(7):1473-1507
pubmed: 35748970
Ann Allergy. 1983 Nov;51(5):487
pubmed: 6638611
Front Immunol. 2018 Apr 23;9:720
pubmed: 29740429
Clin Diagn Lab Immunol. 1999 May;6(3):291-2
pubmed: 10225824
Expert Rev Mol Diagn. 2016;16(2):187-204
pubmed: 26651878
Int J Hyg Environ Health. 2014 Mar;217(2-3):196-204
pubmed: 23726529

Auteurs

Aaruni Khanolkar (A)

Department of Pathology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.
Department of Pathology, Northwestern University, Chicago, IL.

Amy Spiczka (A)

American Society for Clinical Pathology, Chicago, IL.

Tracey L Bonfield (TL)

Department of Genomics and Genome Sciences & Pediatrics, Case Western Reserve University, Cleveland, OH.

Thomas S Alexander (TS)

Incite Health, Inc., Doylestown, PA.

John L Schmitz (JL)

Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Diana Boras (D)

American Society for Clinical Pathology, Chicago, IL.

Karen Fong (K)

American Society for Clinical Pathology, Chicago, IL.

Sarada L Nandiwada (SL)

Department of Pediatrics, Section of Allergy & Immunology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX.

Gerald C Miller (GC)

**Pathology Laboratory Associates, Tulsa, OK.

Anne E Tebo (AE)

Division of Clinical Biochemistry and Immunology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH